Response: Commentary: Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis

Front Oncol. 2023 Oct 30:13:1279862. doi: 10.3389/fonc.2023.1279862. eCollection 2023.

May Soe Thu^{1

2

3}, Krit Pongpirul^{3

4

5

6

7}

¹ Joint Chulalongkorn University - University of Liverpool Ph.D. Programme in Biomedical Sciences and Biotechnology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
² Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
³ Department of Infection Biology and Microbiomes, Faculty of Health and Life Science, University of Liverpool, Liverpool, United Kingdom.
⁴ Center of Excellence in Preventive & Integrative Medicine, Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
⁵ School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
⁶ Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
⁷ Clinical Research Center, Bumrungrad International Hospital, Bangkok, Thailand.

No abstract available

Keywords: breast cancer; cancer staging; microbiome; standard deviation; standard error.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.